You are here :
Home
Healthcare Market Research Reports
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
 |
Cardiac Monitoring Devices The Global Cardiac Monitoring Devices Market pegged at $ 15.7 billion in 2012 is expected to be $20.1 billion by 2018, growing at a CAGR of 4.8%.The Global Cardiac Monitoring Devices Market can be segmented on the basis of devices, geography, Companies and Macroindicator.Deep dive analysis of the top players of this market have been considered in this report. |
Upcoming |
|
|
Brain Monitoring Devices The Global Brain Monitoring Devices Market, mainly driven by rising incidences of autoimmune and cardiovascular diseases, brain disorders and sleep disorders. The global brain monitoring market was valued at $1164.05 million in 2013 and is poised to grow at a CAGR of 8.6% to reach $1639.4 million by 2018. The Brain Monitoring Devices Market segmentation by products such as Electroencephalograph, Transcranial Doppler, Magnetoencephalograph, Intracranial Pressure Monitor, Cerebral Oximeter, and Acessories & by Application Sleep Disorders, Epilepsy, Traumatic Brain Injury, Brain Death. The main companies operating in Brain monitoring devices market and extensively covered in this report are Nihon Kohden Corporation, Nonin Medical Inc, Elekta AB, and Advanced Brain Monitoring, Inc., Yokogawa, Grass Technologies, Compumedics Ltd, Cadwell Laboratories |
Upcoming |
|
|
Facial Aesthetics Devices Facial Aesthetics Devices and Surgical Equipment, Ablation... |
Upcoming |
|
|
Telemonitoring Telemonitoring and Wireless Health, Telemedicine and |
Upcoming |
|
|
Global Implantable Drug Delivery Devices Market The Global Implantable Drug Delivery Market is mainly driven by growing prevalence of target disease segments such as Prostate Cancer, diabetic retinopathy, chronic pain causing diseases, cardiovascular diseases, Colorectal Cancer, and a rapid aging global population.The Market was Valued at $9.05 billion in 2013 and expected to be $12.42 billion by 2018, growing at a CAGR of 6.5 %. The Implantable Drug Delivery Market analyzes the market by segments such as Drug eluting stents, Infusion Pumps, Intraocular Implants, Brachytherapy Seeds, Contraceptive Implants.The prominent players in the Market are Boston Scientific, Abbott Laboratories, Medtronic, Allergen INC, Merck, Bayer Pharma AG, Arrow International, Theragenics, Varian Medical Systems, and Eckert Ziegler. |
Upcoming |
|
|
Ophthalmology Diagnostic and Monitoring Devices Global ophthalmology diagnostic and monitoring devices market is estimated to grow at a CAGR of 5.8% from 2014 to 2019. The global ophthalmology diagnostic and monitoring devices market is primarily driven by the optical coherence tomography (OCT), which is a non-invasive and non-contact technology used to obtain cross sections of the anterior and posterior segments of the eye. |
Upcoming |
|
|
Ophthalmology Surgery Devices Opthalmology surgery devices have gained a significant share in the total opthalmology devices market. The market is pegged at $5,268.7 million in 2013 and is estimated to achieve $7,401.4 million by 2018, with a growing CAGR of 7.0%. These devices can be segmented by opthalmic surgeries and devices used in them, major geographies, end users, companies, and macro indicators. Deep-dive analysis of the top players of this market have been considered in this report. |
Upcoming |
|
|
Dental Radiology Equipment Dental radiology equipment has gained importance due to its varied application. The global dental radiology equipment market can be segmented by geographies, products, end users, companies, and macro indicators. Deep dive analysis of the top players of this market has been considered in this report. |
Upcoming |
|
|
Nuclear Imaging The Global NUCLEAR MEDICINE Devices Market, mainly driven by increasing awareness, rising incidence of various diseases associated with the ageing population, and increasing investments, funds, grants by government bodies. The market was pegged at $3.5 billion in 2013 and expected to be $5.0 billion by 2018, growing at a CAGR of 7.0%. The technology segment of global NUCLEAR MEDICINE devices market commanded the largest share of total NUCLEAR MEDICINE Devices Market. The report “NUCLEAR MEDICINE Devices Market forecast, 2012-2018 “analyzes the market of NUCLEAR MEDICINE devices by 2 major segments such as NUCLEAR MEDICINE devices, by technology and NUCLEAR MEDICINE devices, by portability. The report also provides an extensive competitive landscaping of companies operating in this market. |
Upcoming |
|
|
Intranasal Drug Delivery Systems Intranasal Drug Delivery Systems and Injectables Drug Delivery devices, |
Upcoming |
|
|
Global Transdermal Drug Delivery Systems Market The Global Transdermal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs using advanced oral delivery systems, huge investment made by big pharmaceutical companies on in-house capabilities for the development of oral drug delivery technologies.The Market was Valued at $13.5 billion in 2013 and expected to be $21.7 billion by 2018, growing at a CAGR of 11.1%. The Transdermal Drug Delivery Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven. |
Upcoming |
|
|
Stroboscope Stroboscope and Brachoscope, Laryngoscope, |
Upcoming |
|
|
Brachoscope Brachoscope and Stroboscope, Laryngoscope, |
Upcoming |
|
|
Laryngoscope Laryngoscope and Stroboscope, Brachoscope, |
Upcoming |
|
|
Otoscope Otoscope and Stroboscope, Brachoscope, |
Upcoming |
|
|
Nasopharyngoscope Nasopharyngoscope and Stroboscope, Brachoscope, |
Upcoming |
|
|
Pharyngoscope Pharyngoscope and Stroboscope, Brachoscope, |
Upcoming |
|
|
Microdebrider Microdebrider and Stroboscope, Brachoscope, |
Upcoming |
|
|
ENT Instruments ENT Instruments and Stroboscope, Brachoscope, |
Upcoming |
|
|
Neurointerventional Device Market The global Neurointerventional devices market is estimated to be $1544.79 million in 2013 and is expected to grow at a CAGR of 6.8% to reach $1944.7 million by 2018. The Neurointerventional Devices market segmentation by 5 segments such as neurothrombectomy devices (suction/aspiration device, clot retriever, and snare device), cerebral angiography and stenting system (carotid stent, and embolic protection system), aneurysm coiling devices (platinum coil, liquid embolic agents, and flow diversion device) and support devices (microcatheter, and microguidewire). The major players operating in Neurointerventional device market and extensively covered in this report are Covidien, PLC (Ireland), Stryker Corporation (U.S.), Johnson & Johnson (U.S.), and Penumbra, Inc. (U.S.). |
Upcoming |
Healthcare
